Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1961 1
1963 1
1966 1
1968 1
1969 2
1970 1
1971 1
1973 1
1974 2
1976 4
1977 1
1978 7
1979 3
1980 4
1981 4
1982 3
1983 6
1984 3
1985 4
1986 6
1987 3
1988 5
1989 5
1990 7
1991 5
1992 8
1993 9
1994 12
1995 29
1996 13
1997 14
1998 15
1999 18
2000 22
2001 37
2002 22
2003 29
2004 58
2005 65
2006 69
2007 76
2008 91
2009 112
2010 84
2011 127
2012 155
2013 173
2014 182
2015 243
2016 207
2017 251
2018 302
2019 329
2020 412
2021 468
2022 510
2023 231

Text availability

Article attribute

Article type

Publication date

Search Results

4,004 results

Results by year

Filters applied: . Clear all
Page 1
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes.
Huang Q, Wu X, Wang Z, Chen X, Wang L, Lu Y, Xiong D, Liu Q, Tian Y, Lin H, Guo J, Wen S, Dong W, Yang X, Yuan Y, Yue Z, Lei S, Wu Q, Ran L, Xie L, Wang Y, Gao L, Tian Q, Zhou X, Sun B, Xu L, Tang Z, Ye L. Huang Q, et al. Among authors: wen s. Cell. 2022 Oct 27;185(22):4049-4066.e25. doi: 10.1016/j.cell.2022.09.020. Epub 2022 Oct 7. Cell. 2022. PMID: 36208623
Potassium channels and epilepsy.
Gao K, Lin Z, Wen S, Jiang Y. Gao K, et al. Among authors: wen s. Acta Neurol Scand. 2022 Dec;146(6):699-707. doi: 10.1111/ane.13695. Epub 2022 Oct 12. Acta Neurol Scand. 2022. PMID: 36225112 Review.
CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.
Xiao M, Xie L, Cao G, Lei S, Wang P, Wei Z, Luo Y, Fang J, Yang X, Huang Q, Xu L, Guo J, Wen S, Wang Z, Wu Q, Tang J, Wang L, Chen X, Chen C, Zhang Y, Yao W, Ye J, He R, Huang J, Ye L. Xiao M, et al. Among authors: wen s. J Immunother Cancer. 2022 May;10(5):e004022. doi: 10.1136/jitc-2021-004022. J Immunother Cancer. 2022. PMID: 35580929 Free PMC article.
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: wen sw. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
4,004 results